Excerpt from Oman Observer on the actual launch of Nexa in Feb. Suggest an expanded "opportunity" is valid.
Worth reading the bolded paragraphs re Ministry of Health partnership, what experts pointed out and discussions re several other countries healthcare programs.
Full article in link.Nexa tech innovation offers hope for epilepsy patients
MUSCAT, FEB 24'Onsor,' a company under the Ithca Group, launched the groundbreaking 'Nexa' technology. This breakthrough innovation marks a...www.omanobserver.omOman
Nexa tech innovation offers hope for epilepsy patients
Published: 05:02 PM,Feb 24,2025 | EDITED : 09:02 PM,Feb 24,2025
.....
The event included a live demonstration of the 'Nexa' technology in action, showing how the system works to monitor patients’ health through advanced sensors and artificial intelligence algorithms. This innovative approach allows users to track their condition, reducing the frequency of sudden seizures and limiting their potentially serious consequences. The integration of AI into the technology further enhances its accuracy and effectiveness, ensuring patients receive timely warnings that empower them to manage their health more effectively.
One of the key highlights of the launch was the strategic partnership between Onsor and the Ministry of Health. This collaboration aims to leverage vast amounts of data collected by 'Nexa' to support medical research and provide invaluable insights into epilepsy treatment. The technology will also be used to provide advisory services to doctors and specialists, ensuring that patients receive the best possible care.
Experts in the field of health technology pointed out that 'Nexa' could serve as the foundation for expanding the use of neuromorphic computing in other areas of healthcare, including chronic neurological diseases and heart conditions.
The company has also expressed interest in collaborating with major international research centres and hospitals to expand the use of the technology globally, with ongoing discussions about integrating 'Nexa' into smart healthcare programmes in several countries.
The launch of 'Nexa' represents yet another milestone in Oman's vision to position itself as a regional hub for technological innovation in the healthcare sector. By providing a solution that allows epilepsy patients to regain control over their health, 'Nexa' has not only changed the lives of those directly impacted but has also opened doors for other innovative health solutions that could positively affect millions of people worldwide.
With this transformative innovation, 'Nexa' brings renewed hope to epilepsy patients, offering them the opportunity to live with greater confidence and security. The event concluded with Onsor reaffirming its commitment to developing advanced technological solutions that have a positive impact on people’s lives, further enhancing Oman’s standing as a leader in health and technology innovation.
- Forums
- ASX - By Stock
- BRN
- 2025 BrainChip Discussion
BRN
brainchip holdings ltd
Add to My Watchlist
0.00%
!
20.0¢

2025 BrainChip Discussion, page-3976
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
20.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $405.0M |
Open | High | Low | Value | Volume |
20.5¢ | 21.0¢ | 20.0¢ | $1.544M | 7.615M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 61852 | 20.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
20.5¢ | 217258 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 32537 | 0.200 |
25 | 968327 | 0.195 |
38 | 1574473 | 0.190 |
40 | 1943108 | 0.185 |
65 | 1281316 | 0.180 |
Price($) | Vol. | No. |
---|---|---|
0.205 | 179258 | 6 |
0.210 | 1653584 | 26 |
0.215 | 846002 | 16 |
0.220 | 1267378 | 34 |
0.225 | 840448 | 18 |
Last trade - 16.20pm 27/06/2025 (20 minute delay) ? |
Featured News
BRN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online